PANCE Blueprint Pulmonary (9%)

Pulmonary hypertension

Patient will present as → a 43-year-old woman with a history of COPD presents to your office with worsening dyspnea, especially at rest. She also complains of dull, retrosternal chest pain. On examination, she has persistent widened splitting of S2. Radiographic findings demonstrate peripheral “pruning” of the large pulmonary arteries.

**Peripheral “pruning” of the large pulmonary arteries is characteristic of pulmonary hypertension in severe emphysema

Pulmonary Hypertension (PH) is defined as increased pressure in the pulmonary arteries, leading to right ventricular strain and potential heart failure

  • Blood pressure in the lungs is usually very low, 15/5. In pulmonary hypertension, the pressure increases > 20 mmHg at rest
  • It can be due to left heart disease, chronic lung disease, or conditions that specifically cause pulmonary arterial hypertension
  • Left heart disease (heart failure, especially with preserved ejection fraction) is the most common cause of pulmonary HTN overall. Mitral stenosis is the classic valvular cause: the mitral valve is so tight that blood can’t pass into the left ventricle, which backs pressure up into the lungs
  • Symptoms include dyspnea on exertion, fatigue, chest pain, and syncope in advanced stages; may also present with leg edema and signs of right heart failure • Physical findings include loud P2 heart sound, right ventricular heave, and signs of right heart strain (e.g., jugular venous distension, peripheral edema)
  • The pressure can become so great that the right heart can no longer pump against the vascular resistance, which leads to right heart failure and Cor Pulmonale

World Health Organization Pulmonary Hypertension Groups

  1. Pulmonary Arterial Hypertension
  2. Pulmonary Hypertension due to left heart disease
  3. Pulmonary Hypertension due to lung disease
  4. Pulmonary Hypertension due to blood clots in the lungs
  5. Blood and other rare disorders that lead to Pulmonary Hypertension
Schwere pulmonale Hypertonie 51W - CR pa - 001

The classic findings on chest radiography in a patient with pulmonary arterial hypertension include enlarged central pulmonary arteries that taper distally (peripheral pruning), attenuated peripheral vessels, and oligemic lung fields.

Pulmonary hypertension is difficult to diagnose early on as signs and symptoms are often related to the underlying cause

  • Transthoracic echocardiogram (first diagnostic test for pulmonary HTN)
    • Increased pressure in pulmonary arteries, right ventricles → dilated pulmonary artery
    • Dilatation/hypertrophy of right atrium, right ventricle
    • Large right ventricle → bulging septum
  • Right heart catheterization is the GOLD STANDARD for diagnosis of pulmonary HTN → most accurate measure of pressures
  • In pulmonary hypertension, the pressure increases > 20 mmHg at rest
  • Chest X-Ray - The classic findings on chest radiography in a patient with pulmonary arterial hypertension include enlarged central pulmonary arteries that taper distally (peripheral pruning), attenuated peripheral vessels, and oligemic lung fields.
  • ECG → Right heart strain pattern: T wave inversion in right precordial (V1–V4), and inferior leads (II, III, aVF)

Diagnostic algorithm for pulmonary hypertension

Pulmonary hypertension workup algorithm

Identify and treat the underlying cause

  • Pulmonary hypertension secondary to left ventricular failure → optimize left ventricular function
    • Diuretics (cautiously—individuals may be preload dependent)
    • Digoxin
    • Anticoagulants
  • Pulmonary arterial hypertension (WHO group 1) — confirmed by right heart catheterization
    • Relax smooth muscle (promote vasodilation), reduce vascular remodeling, improve exercise capacity with prostanoids, phosphodiesterase inhibitors, endothelin antagonists
    • Not used for pulmonary HTN due to left heart disease or lung disease (can worsen pulmonary edema or hypoxemia)
  • PAH drug classes to know
    • Endothelin receptor antagonists
    • Prostanoids
osmosis Osmosis
Question 1
A 70-year-old woman with hypertension, obesity, and heart failure with preserved ejection fraction has worsening exertional dyspnea. Echocardiography shows an estimated pulmonary artery systolic pressure of 55 mmHg, a dilated left atrium, and a normal left ventricular ejection fraction. Which of the following is the most likely cause of her pulmonary hypertension?
A
Chronic thromboembolic disease
Hint:
Chronic thromboembolic pulmonary hypertension (group 4) follows prior pulmonary emboli and is diagnosed with a V/Q scan; nothing here suggests prior clots.
B
Idiopathic pulmonary arterial hypertension
Hint:
Idiopathic pulmonary arterial hypertension (group 1) is rare, typically affects younger women, and is a diagnosis of exclusion.
C
Left heart disease
D
Lung disease (COPD or interstitial lung disease)
Hint:
Pulmonary hypertension from lung disease (group 3) needs significant COPD, interstitial lung disease, or chronic hypoxemia, which she does not have.
E
Sarcoidosis
Hint:
Sarcoidosis is a group 5 cause and would show lung or systemic findings.
Question 1 Explanation: 
Left heart disease (WHO group 2) is the most common cause of pulmonary hypertension. Raised left atrial pressure from heart failure (especially with preserved ejection fraction) or mitral and aortic valve disease backs up into the pulmonary veins and arteries. A dilated left atrium in a patient with hypertension and obesity is the clue. Treatment targets the heart failure; pulmonary arterial hypertension drugs are not used for group 2 disease and can worsen pulmonary edema. Lung disease and hypoxia (group 3) is the second most common cause.
Question 2
A 45-year-old woman has progressive exertional dyspnea and fatigue. Examination shows a loud P2 and a right ventricular heave. Transthoracic echocardiography shows an estimated pulmonary artery systolic pressure of 60 mmHg with a dilated right ventricle. Which of the following is the most appropriate test to confirm the diagnosis?
A
Chest radiograph
Hint:
A chest radiograph can show enlarged central pulmonary arteries but cannot measure pressures.
B
CT pulmonary angiography
Hint:
CT pulmonary angiography looks for acute pulmonary emboli; it does not measure pulmonary artery pressure.
C
Pulmonary function testing
Hint:
Pulmonary function tests look for an underlying lung cause but do not confirm pulmonary hypertension.
D
Right heart catheterization
E
Ventilation-perfusion scan
Hint:
A V/Q scan screens for chronic thromboembolic pulmonary hypertension once pulmonary hypertension is suspected; it does not confirm the diagnosis.
Question 2 Explanation: 
Echocardiography is the best first test and estimates pulmonary pressures, but right heart catheterization is the gold standard that confirms pulmonary hypertension: a resting mean pulmonary arterial pressure greater than 20 mmHg. Catheterization also measures pulmonary capillary wedge pressure (to separate left heart disease from pulmonary arterial hypertension) and allows vasoreactivity testing. The workup then looks for the cause, including pulmonary function tests, a V/Q scan for chronic thromboembolic disease, and sleep studies.
Question 3
A 34-year-old woman has progressive exertional dyspnea. Right heart catheterization confirms idiopathic pulmonary arterial hypertension with a mean pulmonary arterial pressure of 48 mmHg and a negative vasoreactivity test. She has no heart or lung disease and can do ordinary activities with mild symptoms. Which of the following is the most appropriate initial therapy?
A
Ambrisentan plus tadalafil
B
Amlodipine
Hint:
High-dose calcium channel blockers are reserved for the small group with a positive vasoreactivity test; they can be harmful in nonresponders.
C
Furosemide alone
Hint:
Diuretics treat fluid retention from right heart failure but do not treat the pulmonary vasculopathy.
D
Metoprolol
Hint:
Beta-blockers have no role in pulmonary arterial hypertension and can worsen right ventricular function.
E
Warfarin
Hint:
Routine anticoagulation is no longer recommended for most patients with idiopathic pulmonary arterial hypertension.
Question 3 Explanation: 
For pulmonary arterial hypertension (WHO group 1) with a negative vasoreactivity test and low-to-intermediate risk, current guidance recommends starting combination therapy with an endothelin receptor antagonist (ambrisentan, bosentan, or macitentan) plus a phosphodiesterase-5 inhibitor (tadalafil or sildenafil). Prostanoids such as epoprostenol are added for high-risk disease. These pulmonary vasodilators are used only for group 1 disease, not for pulmonary hypertension caused by left heart disease or lung disease, where treatment targets the underlying cause.
Question 4
A 52-year-old woman with progressive exertional dyspnea undergoes right heart catheterization. Which of the following resting mean pulmonary arterial pressures establishes the diagnosis of pulmonary hypertension?
A
Greater than 10 mm Hg
Hint:
A normal resting mean pulmonary arterial pressure is about 8 to 20 mm Hg, so 10 mm Hg is within the normal range.
B
Greater than 15 mm Hg
Hint:
A mean pulmonary arterial pressure of 15 mm Hg is normal.
C
Greater than 20 mm Hg
D
Greater than 25 mm Hg
Hint:
25 mm Hg was the older threshold. The current definition uses a mean pulmonary arterial pressure greater than 20 mm Hg.
E
Greater than 30 mm Hg
Hint:
30 mm Hg is well above the diagnostic threshold; using it would miss patients with mild pulmonary hypertension.
Question 4 Explanation: 
Pulmonary hypertension is defined hemodynamically as a resting mean pulmonary arterial pressure (mPAP) greater than 20 mm Hg measured by right heart catheterization. Blood pressure in the pulmonary circulation is normally very low; a normal resting mPAP is about 8 to 20 mm Hg.

Older definitions used a threshold of 25 mm Hg or greater, so 25 mm Hg is the classic trap. Echocardiography can estimate pulmonary pressures and screen for the disease, but right heart catheterization is required to confirm the diagnosis.
There are 4 questions to complete.
List
Return
Shaded items are complete.
1234
Return

References: Merck Manual · UpToDate

Pulmonary embolism (ReelDx) (Prev Lesson)
(Next Lesson) Restrictive Pulmonary Disease (PEARLS)
Back to PANCE Blueprint Pulmonary (9%)

NCCPA™ CONTENT BLUEPRINT

🤖 NEW: Smarty PANCE now connects directly to your favorite AI tool. It builds custom exams from your weak areas, and it's included with your membership!

X